NCT00199524

Brief Summary

Patients with upper ureteral or renal stones will be randomized to undergoing ureteroscopy with or without a ureteral access sheath. The sheath is designed to facilitate ureteroscope insertion and re-insertion, thus allowing fragments to be basketed out. Stone free rates at 3 months will be determined between the two groups. The investigators hypothesize that the use of the ureteral access sheath with ureteroscopy will result in improved stone free rates at 3 months compared to ureteroscopy without use of a sheath.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2005

Longer than P75 for phase_4

Geographic Reach
1 country

5 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2005

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

October 14, 2009

Status Verified

October 1, 2009

Enrollment Period

3.8 years

First QC Date

September 13, 2005

Last Update Submit

October 13, 2009

Conditions

Keywords

ureteroscopystone free

Outcome Measures

Primary Outcomes (1)

  • The primary end point is the stone free rate at 3 months post ureteroscopy.

    3 months post ureteroscopy

Secondary Outcomes (1)

  • Secondary end points include operative and surgical factors such as operative time, stone size, stone location, stone composition, patient sex and the presence of a ureteric stent post-op.

    at time of intervention

Study Arms (2)

1

ACTIVE COMPARATOR

ureteroscopy with ureteral access sheath

Device: Navigator Ureteral Access Sheath

2

NO INTERVENTION

ureteroscopy without ureteral access sheath

Interventions

ureteral access sheath

Also known as: Navigator Ureteral Access Shealth
1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Upper ureteral (proximal to iliac vessels/iliac crest) calculi;
  • Renal calculi;
  • Normal renal function;
  • Any stone composition;
  • Single or multiple stones(planned treatment of all stones at this surgery);
  • Age \> 18 years;
  • Able and willing to return treatment centre for follow-up visits; AND
  • Signed study consent

You may not qualify if:

  • Ureteric calculi distal to the level of the iliac vessels/iliac crest;
  • Failed ureteroscopy for same stone (i.e. has to be the first ureteroscopic procedure for this stone, however a prior failed extracorporeal shockwave lithotripsy (SWL) is acceptable);
  • Bilateral ureteroscopy;
  • If an adjunctive procedure is planned post ureteroscopy (e.g. percutaneous nephrolithotomy, SWL) (i.e. it is known preoperatively that a ureteroscopic procedure will not render the patient stone free and that ancillary procedures will be necessary);
  • If in the investigators opinion, enrollment would be not be appropriate; OR
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Edmonton Prostate and Urological Research Centre

Edmonton, Alberta, T5H 4B9, Canada

Location

The Prostate Centre at Vancouver General Hospital

Vancouver, British Columbia, V5Z 3J5, Canada

Location

Centre for Advanced Urological Research at Queen's University

Kingston, Ontario, M5B 1W8, Canada

Location

Urology at St. Joseph's Hospital, The University of Western Ontario

London, Ontario, N6A 4V2, Canada

Location

Kidney Stone Program at St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

MeSH Terms

Conditions

Urinary Calculi

Condition Hierarchy (Ancestors)

UrolithiasisUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Hassan Razvi, MD, FRCSC

    Urology, St. Joseph's Hospital, The University of Western Ontario

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 20, 2005

Study Start

May 1, 2005

Primary Completion

March 1, 2009

Study Completion

May 1, 2009

Last Updated

October 14, 2009

Record last verified: 2009-10

Locations